399 results on '"Kim, John S."'
Search Results
2. Demographic and Clinical Factors Associated With SARS-CoV-2 Spike 1 Antibody Response Among Vaccinated US Adults: the C4R Study
3. PCSK6 and Survival in Idiopathic Pulmonary Fibrosis
4. MUC5B, telomere length and longitudinal quantitative interstitial lung changes: the MESA Lung Study
5. Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants.
6. A multidimensional classifier to support lung transplant referral in patients with pulmonary fibrosis
7. Comparison of Pirfenidone and Nintedanib: Post Hoc Analysis of the CleanUP-IPF Study
8. Associations of Plasma Omega-3 Fatty Acids With Progression and Survival in Pulmonary Fibrosis
9. Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial
10. Adiposity and Interstitial Lung Abnormalities in Community-Dwelling Adults The MESA Cohort Study
11. Effect of a standardized fluid management algorithm on acute kidney injury and mortality in pediatric patients on extracorporeal support
12. Point-of-Care Ultrasound-Guided Procedures in the Pediatric Cardiac Intensive Care Unit
13. Associations of Serum Adipokines With Subclinical Interstitial Lung Disease Among Community-Dwelling Adults The Multi-Ethnic Study of Atherosclerosis (MESA)
14. Diagnostic Utility of Point-of-Care Ultrasound in the Pediatric Cardiac Intensive Care Unit
15. Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association study
16. Biological Age, Chronological Age and Survival in Pulmonary Fibrosis: A Causal Mediation Analysis
17. Transcriptome-Wide Association Study of Idiopathic Pulmonary Fibrosis Survival Identifies PTPN9 and SNRPB2.
18. Molecular Endotypes of Idiopathic Pulmonary Fibrosis: A Latent Class Analysis of Two Multicenter Observational Cohorts.
19. Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine.
20. TOLLIP SNP and Antimicrobial Treatment Effect in Idiopathic Pulmonary Fibrosis.
21. Machine Learning of Plasma Proteomics Classifies Diagnosis of Interstitial Lung Disease.
22. A Multi-dimensional Classifier to Support Lung Transplant Referral in Patients with Pulmonary Fibrosis
23. Multisystem Inflammatory Syndrome Associated with COVID-19 Anti-thrombosis Guideline of Care for Children by Action
24. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases
25. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases
26. Commensal Oral Microbiota, Disease Severity, and Mortality in Fibrotic Lung Disease.
27. Proteomic Biomarkers of Survival in Idiopathic Pulmonary Fibrosis.
28. Commensal Oral Microbiota, Disease Severity and Mortality in Fibrotic Lung Disease
29. Approach to Clinical Trials for the Prevention of Pulmonary Fibrosis
30. Nonlinear associations between computed tomography‐measures of adiposity and long pentraxin‐3 in the Multi‐Ethnic Study of Atherosclerosis
31. Comparison of Pirfenidone and Nintedanib: Post-Hoc Analysis of the CleanUP-IPF Study
32. Medical and Invasive Management of Cardiac Thrombosis in Children with Congenital and Acquired Heart Disease
33. Thromboelastography-guided management of coagulopathy in neonates with congenital diaphragmatic hernia supported by extracorporeal membrane oxygenation
34. The Compensatory Reserve Index Responds to Acute Hemodynamic Changes in Patients with Congenital Heart Disease: A Proof of Concept Study
35. Nonlinear associations between computed tomography‐measures of adiposity and long pentraxin‐3 in the Multi‐Ethnic Study of Atherosclerosis.
36. Proteomic Biomarkers of Survival in Idiopathic Pulmonary Fibrosis
37. Associations of Plasma Omega-3 Fatty Acids With Progression and Survival in Pulmonary Fibrosis
38. Mapping the Proteomic Landscape of Radiological Lung Abnormalities.
39. A Polygenic Risk Score for Idiopathic Pulmonary Fibrosis and Interstitial Lung Abnormalities
40. Hyperpolarized Xenon-129: A New Tool to Assess Pulmonary Physiology in Patients with Pulmonary Fibrosis
41. Incidence of Interstitial Lung Abnormalities: The MESA Lung Study
42. Accuracy of Bedside Ultrasound Femoral Vein Diameter Measurement by PICU Providers*
43. Associations between eGFR and albuminuria with right ventricular measures: the MESA-Right ventricle study
44. Risk Factors for Venous Thromboembolic Events in Children With Acute Musculoskeletal Infections
45. Abstract P540: Cardiovascular Disease Risk Factors and Antibody Response to COVID-19 Vaccination: The C4R Study
46. Obstructive Sleep Apnea and Longitudinal Changes in Interstitial Lung Imaging and Lung Function: The MESA Study
47. Central lung gene expression associates with myofibroblast features in idiopathic pulmonary fibrosis
48. Approach to Clinical Trials for the Prevention of Pulmonary Fibrosis
49. Predictors of Mortality in Light Chain Cardiac Amyloidosis with Heart Failure
50. Case Report: Catheter-based mechanical thrombectomy using the Indigo aspiration system in a case of systemic-to-pulmonary shunt thrombosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.